{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:13:41Z","timestamp":1778699621522,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,2,21]],"date-time":"2014-02-21T00:00:00Z","timestamp":1392940800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl."],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00103-013-1903-2","type":"journal-article","created":{"date-parts":[[2014,2,21]],"date-time":"2014-02-21T06:55:12Z","timestamp":1392965712000},"page":"294-301","source":"Crossref","is-referenced-by-count":10,"title":["Fr\u00fcherkennung des Zervixkarzinoms in Deutschland","Early detection of cervical cancer in Germany"],"prefix":"10.1007","volume":"57","author":[{"given":"U.","family":"Seifert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J.","family":"Klug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,21]]},"reference":[{"key":"1903_CR1","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1093\/annonc\/mdr015","volume":"22","author":"Arbyn","year":"2011","unstructured":"Arbyn M, Castellsague X, Sanjos\u00e9 S de et al (2011) Worldwide burden of cervical cancer in 2008. Ann Oncol 22:2675\u20132686","journal-title":"Ann Oncol"},{"key":"1903_CR2","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893\u20132917","journal-title":"Int J Cancer"},{"key":"1903_CR3","unstructured":"Gesellschaft der Epidemiologischen Krebsregister in Deutschland e.V., Robert Koch-Institut (2012) Krebs in Deutschland 2007\u20132008. H\u00e4ufigkeiten und Trends (8. Ausgabe ed.), Berlin"},{"key":"1903_CR4","unstructured":"Gesellschaft der Epidemiologischen Krebsregister in Deutschland e.V., Robert Koch-Institut (2010) Krebs in Deutschland 2005\/2006. H\u00e4ufigkeiten und Trends (7. Ausgabe ed.), Berlin"},{"key":"1903_CR5","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3109\/0284186X.2012.708105","volume":"51","author":"Chen","year":"2012","unstructured":"Chen T, Jansen L, Gondos A et al (2012) Survival of cervical cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage. Acta Oncol 51:915\u2013921","journal-title":"Acta Oncol"},{"key":"1903_CR6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ijc.22683","volume":"121","author":"Gondos","year":"2007","unstructured":"Gondos A, Arndt V, Holleczek B et al (2007) Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis. Int J Cancer 121:395\u2013400","journal-title":"Int J Cancer"},{"key":"1903_CR7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/jnci\/85.12.958","volume":"85","author":"Schiffman","year":"1993","unstructured":"Schiffman MH, Bauer HM, Hoover RN et al (1993) Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 85:958\u2013964","journal-title":"J Natl Cancer Inst"},{"key":"1903_CR8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0042-6822(91)90816-T","volume":"184","author":"Hausen","year":"1991","unstructured":"Hausen H zur (1991) Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9\u201313","journal-title":"Virology"},{"key":"1903_CR9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ijc.2910520513","volume":"52","author":"Munoz","year":"1992","unstructured":"Munoz N, Bosch FX, Sanjose S de et al (1992) The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 52:743\u2013749","journal-title":"Int J Cancer"},{"key":"1903_CR10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12\u201319","journal-title":"J Pathol"},{"key":"1903_CR11","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J et al (2007) Human papillomavirus and cervical cancer. Lancet 370:890\u2013907","journal-title":"Lancet"},{"key":"1903_CR12","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsague X et al (2010) Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1\u00a0million women with normal cytological findings. J Infect Dis 202:1789\u20131799","journal-title":"J Infect Dis"},{"key":"1903_CR13","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ejca.2009.07.019","volume":"45","author":"De","year":"2009","unstructured":"De Vuyst H, Clifford G, Li N, Franceschi S (2009) HPV infection in Europe. Eur J Cancer 45:2632\u20132639","journal-title":"Eur J Cancer"},{"key":"1903_CR14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","volume":"7","author":"Sanjose","year":"2007","unstructured":"Sanjose S de, Diaz M, Castellsague X et al (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7:453\u2013459","journal-title":"Lancet Infect Dis"},{"key":"1903_CR15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/jmv.20863","volume":"79","author":"Klug","year":"2007","unstructured":"Klug SJ, Hukelmann M, Hollwitz B et al (2007) Prevalence of human papillomavirus types in women screened by cytology in Germany. J Med Virol 79:616\u2013625","journal-title":"J Med Virol"},{"key":"1903_CR16","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/sj.bjc.6600918","volume":"88","author":"Petry","year":"2003","unstructured":"Petry KU, Menton S, Menton M et al (2003) Inclusion of HPV-testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br J Cancer 88:1570\u20131577","journal-title":"Br J Cancer"},{"key":"1903_CR17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/1097-0215(20001120)89:6<529::AID-IJC11>3.0.CO;2-G","volume":"89","author":"Schneider","year":"2000","unstructured":"Schneider A, Hoyer H, Lotz B et al (2000) Screening for high grade cervical intraepithelial neoplasia and cancer by testing for high risk HPV, routine cytology or colposcopy. Int J Cancer 89:529\u2013534","journal-title":"Int J Cancer"},{"key":"1903_CR18","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/jmv.21910","volume":"82","author":"Iftner","year":"2010","unstructured":"Iftner T, Eberle S, Iftner A et al (2010) Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: an epidemiological observational study. J Med Virol 82:1928\u20131939","journal-title":"J Med Virol"},{"key":"1903_CR19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2334-13-135","volume":"13","author":"Petry","year":"2013","unstructured":"Petry KU, Luyten A, Justus A et al (2013) Prevalence of high-risk HPV types and associated genital diseases in women born in 1988\/89 or 1983\/84 \u2013 results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany. BMC Infect Dis 13:135","journal-title":"BMC Infect Dis"},{"key":"1903_CR20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1023\/B:CACO.0000003811.98261.3e","volume":"14","author":"Plummer","year":"2003","unstructured":"Plummer M, Herrero R, Franceschi S et al (2003) Smoking and cervical cancer: pooled analysis of the IARC multi-centric case \u2013 control study. Cancer Causes Control 14:805\u2013814","journal-title":"Cancer Causes Control"},{"key":"1903_CR21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/oxfordjournals.jncimonographs.a003477","volume":"31","author":"Castellsague","year":"2003","unstructured":"Castellsague X, Munoz N (2003) Chapter 3: cofactors in human papillomavirus carcinogenesis \u2013 role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31:20\u201328","journal-title":"J Natl Cancer Inst Monogr"},{"key":"1903_CR22","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","volume":"370","author":"International","year":"2007","unstructured":"International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V et al (2007) Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 370:1609\u20131621","journal-title":"Lancet"},{"key":"1903_CR23","unstructured":"Arbyn M, Anttila A, Jordan J et al (2008) European guidelines for quality assurance in cervical cancer screening, 2.\u00a0Aufl. European Communities, Luxembourg"},{"key":"1903_CR24","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.ejca.2009.07.016","volume":"45","author":"Arbyn","year":"2009","unstructured":"Arbyn M, Rebolj M, De Kok IM et al (2009) The challenges of organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer 45:2671\u20132678","journal-title":"Eur J Cancer"},{"key":"1903_CR25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000201676","volume":"76","author":"Wentzensen","year":"2009","unstructured":"Wentzensen N, Klug SJ (2009) Cervical cancer control in the era of HPV vaccination and novel biomarkers. Pathobiol 76:82\u201389","journal-title":"Pathobiol"},{"key":"1903_CR26","unstructured":"Nationaler Krebsplan \u2013 Handlungsfelder, Ziele und Umsetzungsempfehlungen (2012) Bundesministerium f\u00fcr Gesundheit, Berlin"},{"key":"1903_CR27","unstructured":"Gesetz zur Weiterentwicklung der Krebsfr\u00fcherkennung und zur Qualit\u00e4tssicherung durch klinische Krebsregister (Krebsfr\u00fcherkennungs- und -registergesetz \u2013 KFRG) (2013) Bundesgesetzblatt, 2013 Teil I, 617\u2013623"},{"key":"1903_CR28","unstructured":"Robert Koch-Institut (2010) Verbreitung von Krebserkrankungen in Deutschland. Entwicklung der Pr\u00e4valenzen zwischen 1990 und 2010. Robert Koch Insitut, Berlin"},{"key":"1903_CR29","unstructured":"Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide (Version Version 2.0) [Computer software]. IARCpress, Lyon"},{"key":"1903_CR30","unstructured":"Gemeinsamer Bundesausschuss (2005) Beschlussbegr\u00fcndung \u2013 \u00c4nderung der Richtlinien \u00fcber die Fr\u00fcherkennung von Krebserkrankungen (Krebsfr\u00fcherkennungs-Richtlinien). http:\/\/www.g-ba.de\/downloads\/40-268-48\/2005-07-19-Abstrich_Begruendung.pdf (Zugegriffen: 10. Aug. 2013)"},{"key":"1903_CR31","first-page":"A2246","volume":"104","author":"Kassen\u00e4rztliche","year":"2007","unstructured":"Kassen\u00e4rztliche Bundesvereinigung (2007) Neufassung der Vereinbarung von Qualit\u00e4tssicherungsma\u00dfnahmen nach \u00a7\u00a0135 Abs.\u00a02 SGB V zur zytologischen Untersuchung von Abstrichen der Cervix Uteri. Dtsch \u00c4rztebl 104:A2246\u2013A2451","journal-title":"Dtsch \u00c4rztebl"},{"key":"1903_CR32","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1055\/s-2008-1065364","volume":"70","author":"R\u00fcckinger","year":"2008","unstructured":"R\u00fcckinger S, Tauscher M, Redel R et al (2008) Participation in cervical cancer screening by age and region \u2013 a cohort study with a 3 1\/2 year follow-up on 2,223,135 women in Bavaria. Gesundheitswesen 70:e17\u2013e21","journal-title":"Gesundheitswesen"},{"key":"1903_CR33","unstructured":"Kerek-Bodden H, Altenhofen L, Brenner G, Franke A (2009) Abschlussbericht. Durchf\u00fchrung einer versichertenbezogenen Untersuchung zur Inanspruchnahme der Fr\u00fcherkennung auf Zervixkarzinom in den Jahren 2002, 2003 und 2004 auf der Basis von Abrechnungsdaten. Zentralinstitut f\u00fcr die kassen\u00e4rztliche Versorgung in der Bundesrepublik Deutschland (ZI), Berlin"},{"key":"1903_CR34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ypmed.2010.08.008","volume":"51","author":"Klug","year":"2010","unstructured":"Klug SJ, Taylor KJ, Scheidemann-Wesp U et al (2010) Participation in cervical cancer screening in Germany. Prev Med 51:431\u2013432","journal-title":"Prev Med"},{"key":"1903_CR35","unstructured":"NHS Cervical Screening Programme (2012) NHS Cervical Screening Programme 2012 Annual Review. http:\/\/www.cancerscreening.nhs.uk\/cervical\/publications\/cervical-annual-review-2012.pdf (Zugegriffen: 20. Aug. 2013)"},{"key":"1903_CR36","first-page":"1086","volume":"48","author":"Marquardt","year":"2007","unstructured":"Marquardt K, Broschewitz U, B\u00fcttner HH, Barten M (2007) Zervixkarzinom trotz Fr\u00fcherkennungsprogramm. Frauenarzt 48:1086\u20131088","journal-title":"Frauenarzt"},{"key":"1903_CR37","unstructured":"McCrory DC, Matchar DB, Bastian L et al (1999) Evaluation of cervical cytology. (Evidence Report\/Technology Assessment Number 5 ed.) Agency for Health Care Policy and Research (AHCPR), Rockville (Publication No 99-E010)"},{"key":"1903_CR38","doi-asserted-by":"crossref","first-page":"a1284","DOI":"10.1136\/bmj.a1284","volume":"337","author":"Arbyn","year":"2008","unstructured":"Arbyn M, Kyrgiou M, Simoens C et al (2008) Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 337:a1284","journal-title":"BMJ"},{"key":"1903_CR39","doi-asserted-by":"crossref","first-page":"a1343","DOI":"10.1136\/bmj.a1343","volume":"337","author":"Albrechtsen","year":"2008","unstructured":"Albrechtsen S, Rasmussen S, Thoresen S et al (2008) Pregnancy outcome in women before and after cervical conisation: population based cohort study. BMJ 337:a1343","journal-title":"BMJ"},{"key":"1903_CR40","first-page":"484","volume":"52","author":"Marquardt","year":"2011","unstructured":"Marquardt K (2011) Zervixzytologie: Der repr\u00e4sentative Abstrich. Frauenarzt 52:484","journal-title":"Frauenarzt"},{"key":"1903_CR41","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1067\/mob.2001.116736","volume":"185","author":"Bernstein","year":"2001","unstructured":"Bernstein SJ, Sanchez-Ramos L, Ndubisi B (2001) Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy. Am J Obstet Gynecol 185:308\u2013317","journal-title":"Am J Obstet Gynecol"},{"key":"1903_CR42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0090-8258(03)00176-8","volume":"90","author":"Abulafia","year":"2003","unstructured":"Abulafia O, Pezzullo JC, Sherer DM (2003) Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey. Gynecol Oncol 90:137\u2013144","journal-title":"Gynecol Oncol"},{"key":"1903_CR43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/cncr.11673","volume":"99","author":"Klinkhamer","year":"2003","unstructured":"Klinkhamer PJ, Meerding WJ, Rosier PF, Hanselaar AG (2003) Liquid-based cervical cytology. Cancer 99:263\u2013271","journal-title":"Cancer"},{"key":"1903_CR44","unstructured":"Siebert U, Muth G, Scrozynski G et al (2003) D\u00fcnnschichtpr\u00e4parationen und computergest\u00fctzte Untersuchungen von Zervixabstrichen. Medizinische Effektivit\u00e4t, gesundheits\u00f6konomische Evaluation und systematische Entscheidungsanalyse, 35.\u00a0Aufl. Asgard, Sankt Augustin"},{"key":"1903_CR45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(06)67961-0","volume":"367","author":"Davey","year":"2006","unstructured":"Davey E, Barratt A, Irwig L et al (2006) Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review. Lancet 367:122\u2013132","journal-title":"Lancet"},{"key":"1903_CR46","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.39196.740995.BE","volume":"335","author":"Ronco","year":"2007","unstructured":"Ronco G, Cuzick J, Pierotti P et al (2007) Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial. BMJ 335:28\u201335","journal-title":"BMJ"},{"key":"1903_CR47","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.2009.1569","volume":"302","author":"Siebers","year":"2009","unstructured":"Siebers AG, Klinkhamer PJ, Grefte JM et al (2009) Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. JAMA 302:1757\u20131764","journal-title":"JAMA"},{"key":"1903_CR48","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1002\/ijc.27955","volume":"132","author":"Klug","year":"2013","unstructured":"Klug SJ, Neis KJ, Harlfinger W et al (2013) A randomized trial comparing conventional cytology to liquid-based cytology and computer assistance. Int J Cancer 132:2849\u20132857","journal-title":"Int J Cancer"},{"key":"1903_CR49","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-0032-1327819","volume":"73","author":"Kindermann","year":"2013","unstructured":"Kindermann T, Lier D, Iftner T (2013) Fr\u00fcherkennung. Kategorisierung von HPV-Tests. Geburtshilfe Frauenheilkd 73:28\u201331","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"1903_CR50","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00292-011-1475-6","volume":"32","author":"Wentzensen","year":"2011","unstructured":"Wentzensen N (2011) Molekulare Diagnostik der HPV-Infektion. Pathologe 32:461\u2013466","journal-title":"Pathologe"},{"key":"1903_CR51","unstructured":"Deutsche Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe, Arbeitsgemeinschaft Infektiologie und Infektimmunologie in Gyn\u00e4kologie und Geburtshilfe, Berufsverband der Frauen\u00e4rzte, Deutsche Gesellschaft f\u00fcr Pathologie, Deutsche Gesellschaft f\u00fcr Urologie, Deutsche Krebsgesellschaft et al (2008) Pr\u00e4vention, Diagnostik und Therapie der HPV-Infektion und pr\u00e4invasiver L\u00e4sionen des weiblichen Genitale [AWMF 015\/027 (S2k)]"},{"key":"1903_CR52","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","volume":"124","author":"Meijer","year":"2009","unstructured":"Meijer CJ, Berkhof J, Castle PE et al (2009) Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 124:516\u2013520","journal-title":"Int J Cancer"},{"key":"1903_CR53","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (2011) Nutzenbewertung eines HPV-Tests im Prim\u00e4rscreening des Zervixkarzinoms (Rep. No. 106). Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen, K\u00f6ln"},{"key":"1903_CR54","unstructured":"Mittendorf T, Nocon M, Roll S et al (2007) HPV-DNA-Diagnostik zur Zervixkarzinomfr\u00fcherkennung. Verf\u00fcgbar unter http:\/\/portal.dimdi.de\/de\/hta\/hta_berichte\/hta199_bericht_de.pdf (Zugegriffen: 21. Aug. 2013)"},{"key":"1903_CR55","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jnci\/djj209","volume":"98","author":"Ronco","year":"2006","unstructured":"Ronco G, Segnan N, Giorgi-Rossi P et al (2006) Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst 98:765\u2013774","journal-title":"J Natl Cancer Inst"},{"key":"1903_CR56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.bjc.6603210","volume":"95","author":"Kitchener","year":"2006","unstructured":"Kitchener HC, Almonte M, Wheeler P et al (2006) HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer 95:56\u201361","journal-title":"Br J Cancer"},{"key":"1903_CR57","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","volume":"13","author":"Rijkaart","year":"2012","unstructured":"Rijkaart DC, Berkhof J, Rozendaal L et al (2012) Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol 13:78\u201388","journal-title":"Lancet Oncol"},{"key":"1903_CR58","doi-asserted-by":"crossref","unstructured":"Ronco G, Dillner J, Elfstrom KM et al (2013) Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. The Lancet. doi: 10.1016\/S0140-6736(13)62218-7","DOI":"10.1016\/S0140-6736(13)62218-7"},{"key":"1903_CR59","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00129-012-3130-6","volume":"2013","author":"Jentschke","year":"2013","unstructured":"Jentschke M, Soergel P, Hillemanns P (2013) Neue Biomarker in der Pr\u00e4vention des Zervixkarzinoms. Gyn\u00e4kologe 2013:392\u2013396","journal-title":"Gyn\u00e4kologe"},{"key":"1903_CR60","first-page":"792","volume":"52","author":"Schmidt","year":"2011","unstructured":"Schmidt D (2011) Der Biomarker p16\/Ki-67 in der Zervixkarzinom-Fr\u00fcherkennung. Frauenarzt 52:792\u2013794","journal-title":"Frauenarzt"},{"key":"1903_CR61","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","volume":"137","author":"Saslow","year":"2012","unstructured":"Saslow D, Solomon D, Lawson HW et al (2012) American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 137:516\u2013542","journal-title":"Am J Clin Pathol"},{"key":"1903_CR62","doi-asserted-by":"crossref","unstructured":"Jentschke M, Hillemanns P (2012) Das wird die neue S3-Leitlinie ber\u00fccksichtigen. Gyn\u00e4kol Geburtshilfe 22\u201325","DOI":"10.1007\/s15013-012-0254-7"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-013-1903-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00103-013-1903-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-013-1903-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T17:00:13Z","timestamp":1565197213000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00103-013-1903-2"}},"subtitle":["Evidenz und Umsetzung","Evidence and implementation"],"short-title":[],"issued":{"date-parts":[[2014,2,21]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["1903"],"URL":"https:\/\/doi.org\/10.1007\/s00103-013-1903-2","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,21]]}}}